The private sector can support the ICCP through funding, innovation, and expertise. Pharmaceutical companies, for instance, can contribute by developing new treatments and making them accessible. Additionally, technology firms can provide digital health solutions that improve cancer detection, treatment, and patient management. Collaboration with the private sector can significantly enhance the resources and capabilities available for cancer control.
